ALLERGY RELIEF

Manufacturer
Bi-Mart | ScieGen Pharmaceuticals, INC.
Effective date
2025-04-28
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:00:07

Label at a glance#

ProductALLERGY RELIEF
Active ingredientFEXOFENADINE HYDROCHLORIDE
Label structure10 sections

Indications and uses

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Dosage and administration

adults and children 12 years of age and over take one 180mg tablet with water once a day; do not take more than 1 tablet in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

Storage and handling

store between 20° and 25°C (68° and 77°F) protect from excessive moisture each tablet contains:  sodium 8 mg this product meets the requirements of USP Dissolution Test 2

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Fexofenadine HCl 180 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

kidney disease. Your doctor should determine if you need a different dose.

When using this product:

OTC - WHEN USING SECTION

  • do not take more than directed
  • do not take at the same time as aluminum or magnesium antacids
  • do not take with fruit juices (see Directions)

Stop use and ask a doctor if

OTC - STOP USE SECTION

an allergic reaction to this product occurs. Seek medical help right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding,

ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years of age and over

take one 180mg tablet with water once a day; do not take more than 1 tablet in 24 hours

children under 12 years of age

do not use

adults 65 years of age and older

ask a doctor

consumers with kidney disease

ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • store between 20° and 25°C (68° and 77°F)
  • protect from excessive moisture
  • each tablet contains: sodium 8 mg
  • this product meets the requirements of USP Dissolution Test 2

Inactive ingredients

INACTIVE INGREDIENT SECTION

anhydrous lactose, colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, polyethylene glycol, pregelatinized starch(maize), red iron oxide, stearic acid, titanium dioxide, yellow iron oxide.

Questions?

OTC - QUESTIONS SECTION

Call toll-free  1-844-912-4012

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 37835-601-09

COMPARE TO THE ACTIVE INGREDIENT IN ALLEGRA ®ALLERGY 24 HOUR TABLETS*

NON-DROWSY

ALLERGY RELIEF

FEXOFENADINE HYDROCHLORIDE 180 mg

24 HOUR ALLERGY

ORIGINAL PRESCRIPTION STRENGTH

RELIEF OF:

SNEEZING

RUNNY NOSE

ITCHY, WATER EYES

ITCHY NOSE OR THROAT

ANTIHISTAMINE

90 Tablets

*This product is not manufactured or distributed by the owner of the registered trademark Allegra ®Allergy 24 Hour Tablets.

Distributed by:

BI-MART

Eugene, OR 97402

labellabel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 37835-601-45

COMPARE TO THE ACTIVE INGREDIENT IN ALLEGRA ®ALLERGY 24 HOUR TABLETS*

NON-DROWSY

ALLERGY RELIEF

FEXOFENADINE HYDROCHLORIDE 180 mg

24 HOUR ALLERGY

ORIGINAL PRESCRIPTION STRENGTH

RELIEF OF:

SNEEZING

RUNNY NOSE

ITCHY, WATER EYES

ITCHY NOSE OR THROAT

ANTIHISTAMINE

45 Tablets

*This product is not manufactured or distributed by the owner of the registered trademark Allegra ®Allergy 24 Hour Tablets.

Distributed by:

BI-MART

Eugene, OR 97402

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
997420fexofenadine HCl 180 MG 24 HR Oral TabletPSN1
997420fexofenadine hydrochloride 180 MG Oral TabletSCD1
997420fexofenadine HCl 180 MG 24 HR Oral TabletSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
FEXOFENADINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b893258d-0942-3d8a-3411-056ea0788ff5Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
37835-601-09ALLERGY RELIEF90 in 1 BOTTLETABLET, FILM COATED901
37835-601-45ALLERGY RELIEF45 in 1 BOTTLETABLET, FILM COATED451

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
37835-601ALLERGY RELIEF (FEXOFENADINE HCL) TABLET, FILM COATED [BI-MART]12 package rows20250501_ea8d8e12-4781-4501-a887-e732295d33bf.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
37835-60137835-601-45, 37835-601-09

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
33d56c1c-22da-e750-e063-6294a90ae6d0ea8d8e12-4781-4501-a887-e732295d33bf2025-04-28WarningsExact identifier
spl id: 33d56c1c-22da-e750-e063-6294a90ae6d0
spl set id: ea8d8e12-4781-4501-a887-e732295d33bf

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.